Baupost Group 13F, Q1 2024

Seth Klarman · quarter ending 31 March 2024 · filed 14 May 2024 · SEC CIK 1061768

$3.65B
Filed US book
22
Positions
20.4%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q1 2024

Weights are against the whole filed book. Changes are in shares held, against the Q4 2023 filing.

CompanyTickerValue% of bookvs Q4 2023
LIBERTY GLOBAL LTD$746.37M20.4%unchanged
ALPHABET INCGOOG$450.33M12.3%unchanged
WILLIS TOWERS WATSON PLC LTD$427.81M11.7%unchanged
FIDELITY NATL INFORMATION SVFIS$413.85M11.3%-12% shares
VIASAT INCVSAT$271.91M7.5%-7% shares
CRH PLC$233.72M6.4%-19% shares
CLARIVATE PLC$227.35M6.2%+20% shares
LIBERTY MEDIA CORP DEL$129.27M3.5%-71% shares
LIBERTY GLOBAL LTD$121.73M3.3%unchanged
OUTBRAIN INC$102.55M2.8%new
JAZZ PHARMACEUTICALS PLC$100.39M2.8%unchanged
LIBERTY MEDIA CORP DEL$79.53M2.2%-67% shares
JACOBS SOLUTIONS INCJ$77.91M2.1%-30% shares
EAGLE MATLS INCEXP$71.20M1.9%new
THERAVANCE BIOPHARMA INC$59.15M1.6%-11% shares
WESCO INTL INCWCC$35.24M1.0%new
WARNER BROS DISCOVERY INCWBD$32.42M0.9%-85% shares
HERBALIFE LTD$22.56M0.6%+34% shares
GDS HLDGS LTDGDS$17.29M0.5%new
ALTICE USA INCOPTU$12.46M0.3%unchanged
FORTREA HLDGS INCFTRE$12.19M0.3%new
SOUNDHOUND AI INCSOUN$5.55M0.1%new

What changed since Q4 2023

Against the Q4 2023 filing, Baupost Group opened 6 new positions, added to 2, trimmed 8, left 6 unchanged and exited 7. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

Exited

  • TOWER SEMICONDUCTOR LTDwas $82.73M
  • LIBERTY MEDIA CORP DELwas $69.43M
  • SSNCwas $62.85M
  • GTNwas $33.69M
  • GTXwas $28.95M
  • LIBERTY MEDIA CORP DELwas $26.86M
  • FINCH THERAPEUTICS GROUP INCwas $243.0K

Added to

  • CLARIVATE PLC+20%$227.35M
  • HERBALIFE LTD+34%$22.56M

Trimmed

  • FIS-12%$413.85M
  • VSAT-7%$271.91M
  • CRH PLC-19%$233.72M
  • LIBERTY MEDIA CORP DEL-71%$129.27M
  • LIBERTY MEDIA CORP DEL-67%$79.53M
  • J-30%$77.91M
  • THERAVANCE BIOPHARMA INC-11%$59.15M
  • WBD-85%$32.42M

Other quarters

Source: SEC Form 13F-HR, accession 0001567619-24-000317, filed by BAUPOST GROUP LLC/MA. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.